calcium/vitamin d3 (500 mg/400 iu)
acis arzneimittel gmbh, nemecko - uhličitan vápenatý a cholekalciferol - 39 - soli a ionty pro p.o. a parent. aplikÁciu
strepsils pomaranČ s vitamínom c
reckitt benckiser (czech republic), spol. s r.o. , Česká republika - rôzne - 69 - otorhinolaryngologica
acylpyrin s vitamínom c
herbacos recordati s.r.o., Česká republika - kyselina acetylsalicylová, kombinácie s výnimkou psycholeptík - 07 - analgetica, antipyretica
theraflu forte s vitamínom c s príchuťou lesného ovocia
haleon czech republic s.r.o., Česká republika - paracetamol, kombinácie s výnimkou psycholeptík - 07 - analgetica, antipyretica
pharmaton geriavit
sanofi-aventis slovakia s.r.o. - vitamíny, iné kombinácie - 91 - multivitamÍny a stopovÉ prvky
vitamín e v klíčkovom oleji sol. ad us. vet.
adrovance
n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - osteoporóza, postmenopauza - lieky na liečbu chorôb kostí - liečba postmenopauzálnej osteoporózy u pacientov s rizikom nedostatku vitamínu d. adrovance znižuje riziko vertebrálnych a zlomenín bedra.
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - klopidogrel besilát - peripheral vascular diseases; stroke; myocardial infarction - antitrombotické činidlá - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st segment elevation akútnom infarkte myokardu v kombinácii s asa u medicínsky liečiť pacientov nárok na thrombolytic therapy. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. Ďalšie informácie nájdete v časti 5.